Abbott and Novo Nordisk have entered into a partnership to provide integrated digital solutions to people with diabetes, using insulin. The collaboration will enable insulin data to be shared between Novo Nordisk connected insulin pens and digital health tools compatible with Abbotts FreeStyle Libre portfolio of products.
February 25 2019 3:21 pm